21 / Interim Update from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Autor:	Kate J Newberry, Haley Howell, Pagel John
Rok vydání:	2018
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e3e0400e9c62d160acafd4af61f3e7c6 https://doi.org/10.26226/morressier.5b3b802db1b87b000eceda6c Zobrazit plný text záznamu